Thus, resistance to chemo-immunotherapy in CLL correlates to the activities of glycolytic enzymes LDHA and pyruvate kinase M2 (PKM2), leading to the development of a metabolic score as a diagnostic tool in CLL [422]. Here, LDHA is linked to B-cell chronic lymphocytic leukemia.